Abstract:GMP practice often pays more attention to facility and equipment(hardware) than on quality system(software),and undermines the integration of CMC and GMP,leading to product quality problems typically associated with the change of API sourcing. This paper analyzes the reasons for changing API suppliers,the impact to product quality,the related regulations and policies,and the current status of the industry with respect to API sourcing changes. It may be necessary to conduct indepth scientific study of the new product,as relying on the application product specifications alone may not be able to detect the changed API impurity and particle size. To assess the merit of an API sourcing change,factors other than material cost should be considered,such as the cost of conducting change control RD and compliance activities,and the corporate quality reputation. The government should tighten and streamline the regulation and its enforcement to ensure the same that standard applies nationwide.

Impact on drug quality by change of API sourcing